NEW YORK (Reuters Health) – In infants having surgery for a unilateral congenital cataract, the
short-term costs are lower with contact lenses instead of an implanted intraocular lens and glasses, a new study
shows.
Month: October 2012
Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration
Source: Ophthalmology
Area: News
According to data from the VIEW 1 and VIEW 2 studies published early online in Ophthalmology, and presented at the American Academy of Ophthalmology annual meeting, intravitreal aflibercept dosed monthly or every 2 mo…
Leaders come together to discuss latest advances in neurosciences
Stony Brook Medicine’s Neurosciences Institute brings together leaders in the field of neurosciences to present the latest advances in research and clinical care for neurodegenerative disorders, neuropsychiatric disorders, and neuro-ophthalmology.
Study reveals key chemical process that corrects potential visual errors in low-light conditions
On the road at night or on a tennis court at dusk, the eye can be deceived. Vision is not as sharp as in the light of day, and detecting a bicyclist on the road or a careening tennis ball can be tough.
Cataract Surgery May Be Safer With Antibiotic Injections
Use of intracameral antibiotics at the conclusion of cataract surgery was associated with a significant decrease in endophthalmitis rates. Medscape Medical News
Long term safety of ranibizumab in neovascular age-related macular degeneration: SECURE Study
Source: Ophthalmology
Area: News
The long-term safety of intravitreal ranibizumab 0.5-mg injections in neovascular age-related macular degeneration has been assessed in a 24 month open-label, multicentre, phase IV extension study (SECURE).
…
Vitreomacular Interface Diseases
Vitreomacular adhesion-related disorders could potentially cause rapid deterioration of vision and ocular function. This new study examines the pathophysiology of these disorders and how they can be treated. Expert Review of Ophthalmology
Jetrea Gets FDA Nod for Macular Adhesion
WASHINGTON (MedPage Today) — The FDA has approved ocriplasmin (Jetrea) as the first nonsurgical treatment for symptomatic vitreomacular adhesion.
Clinical and demographic factors impact visual acuity in retinal vasculitis
Just over one-third of individuals with retinal vasculitis will experience vision loss despite undergoing therapy for the condition, while approximately the same proportion will experience some improvement, show study results.
Researchers Clarify Process Controlling Night Vision
On the road at night or on a tennis court at dusk, the eye can be deceived. Vision is not as sharp as in the light of day, and detecting a bicyclist on the road or a careening tennis ball can be tough. New research reveals the key chemical process that…
Quick, cheap eye scan can predict brain damage in people with multiple sclerosis
An inexpensive, five-minute eye scan can accurately assess the amount of brain damage in people with the debilitating autoimmune disorder multiple sclerosis (MS), and offer clues about how quickly the disease is progressing, according to results of two…
Link Between Abnormal Involuntary Eye Movements In Amblyopia And Changes In Subcortical Regions Of Brain
Little is known about oculomotor function in amblyopia, or “lazy eye,” despite the special role of eye movements in vision. A group of scientists has discovered that abnormal visual processing and circuitry in the brain have an impact on fixational sac…
Fact-Checking Healthcare in the 2012 Debates
Healthcare costs, Medicare, and the Affordable Care Act (ACA) were hot topics at the 3 debates held so far this election season. But was the candidates’ rhetoric exaggerated or misleading? Medscape Internal Medicine
Jetrea (Ocriplasmin) Approved For Symptomatic Vitreomacular Adhesion In The Eyes, FDA
A new medication, Jetrea (ocriplasmin), has been approved by the FDA for VMA (symptomatic vitreomacular adhesion), an eye condition related to aging that can lead to complications and vision loss. When the vitreous gel adheres too strongly to the retin…
Visual Processing and Learning Disorders
How important is it for clinicians to be aware of and understand the various learning disorders that could develop in children? This article explains. Current Opinion in Ophthalmology
Ocriplasmin (Jetrea®) approved in US for the treatment of symptomatic vitreomacular adhesion
Source: PharmaLive
Area: News
The FDA has approved ocriplasmin (Jetrea®) in the US for the treatment of symptomatic vitreomacular adhesion, a progressive sight threatening condition, making it the first pharmacological agent to be approved for this i…
FDA Approves Ocriplasmin for Vitreomacular Adhesions
The FDA has approved ocriplasmin intravitreal injection for the treatment of symptomatic vitreomacular adhesions. FDA Approvals
An Observational Study of OPTIVE® Plus for the Treatment of Dry Eye Disease
Status: Recruiting,
Condition Summary: Dry Eye Syndromes
Cat antigen desensitization reduces allergic rhinoconjunctivitis symptoms
NEW YORK (Reuters Health) – Desensitization with a Fel d 1-derived peptide antigen (Cat-PAD) reduces
allergic rhinoconjunctivitis symptoms up to a year after the start of dosing.
Ranibizumab safe long-term for neovascular age-related macular degeneration
NEW YORK (Reuters Health) – Ranibizumab injections may be safely used for at least three years in
patients with neovascular age-related macular degeneration (nAMD), according to findings from the SECURE
study.